Tweedy Browne's BMY Position Overview
Tweedy Browne (via Tweedy, Browne Co LLC) currently holds 14,466 shares of Bristol-Myers Squibb Company (BMY) worth $652,417, representing 0.06% of the portfolio. First purchased in 2025-Q2, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Tweedy Browne has initiated a new position in BMY, representing a fresh investment thesis on this company. Largest addition occurred in Q3 2025, adding 7,282 shares.
Analysis based on 13F filings available since 2013 Q2
Tweedy Browne's Bristol-Myers Squibb Company (BMY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Bristol-Myers Squibb Company (BMY) Trades by Tweedy Browne
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2025 | +7,184 | New Buy | 7,184 | $46.29 |
| Q3 2025 | +7,282 | Add 101.36% | 14,466 | $45.10 |
Tweedy Browne's Bristol-Myers Squibb Company Investment FAQs
Tweedy Browne first purchased Bristol-Myers Squibb Company (BMY) in Q2 2025, acquiring 7,184 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Tweedy Browne has held Bristol-Myers Squibb Company (BMY) for 2 quarters since Q2 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Tweedy Browne's largest addition to Bristol-Myers Squibb Company (BMY) was in Q3 2025, adding 14,466 shares worth $652,417. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Tweedy Browne's firm, Tweedy, Browne Co LLC, owns 14,466 shares of Bristol-Myers Squibb Company (BMY), valued at approximately $652,417. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Bristol-Myers Squibb Company (BMY) represents approximately 0.06% of Tweedy Browne's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Tweedy Browne's peak holding in Bristol-Myers Squibb Company (BMY) was 14,466 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.